Valtrex is a prescription antiviral medication that contains valacyclovir as its active component. Valacyclovir belongs to the antiviral class of drugs and is a prodrug of aciclovir, meaning it is converted in the body to aciclovir, which then interferes with viral DNA replication. Valtrex is available in pill form in two strengths: 500 mg and 1000 mg. In Hong Kong, it is regulated by the Department of Health and is supplied only with a medical prescription.
Valacyclovir is absorbed rapidly from the gastrointestinal tract and is converted by hepatic and intestinal enzymes into aciclovir. Aciclovir is then selectively taken up by virus-infected cells, where viral thymidine kinase adds a phosphate group, forming aciclovir monophosphate. Cellular enzymes complete the conversion to aciclovir triphosphate, which:
These actions stop the replication of herpes viruses, including herpes simplex virus (HSV) types 1 and 2, and varicella-zoster virus (VZV). Because the activation step requires a viral enzyme, healthy cells are largely spared, contributing to the drug’s safety profile. Onset of antiviral activity occurs within a few hours after ingestion, with peak plasma concentrations reached in about 2 hours for the 500 mg dose and slightly later for the 1000 mg dose. The half-life of aciclovir is roughly 2.5-3 hours in individuals with normal renal function, and the drug is eliminated primarily unchanged by the kidneys.
Valtrex is approved by major regulatory agencies, including the U.S. FDA and the European EMA, for the following indications. In Hong Kong, these approvals are recognized and incorporated into local prescribing guidelines:
Typical patient populations include adolescents and adults with confirmed HSV or VZV infection. Valtrex is not indicated for prophylaxis of herpes infections in immunocompetent individuals without a documented outbreak.
Absolute contraindications
Known hypersensitivity to valacyclovir, aciclovir, or any excipients in the tablet.
Severe renal impairment where the drug cannot be adequately cleared (e.g., creatinine clearance < 10 mL/min) without dose adjustment.
Relative contraindications
Moderate renal dysfunction (creatinine clearance 10-50 mL/min) - dose reduction is required.
Pregnancy and lactation: Valacyclovir crosses the placenta and is excreted in breast milk. Use only if the potential benefit justifies the potential risk; a physician should evaluate each case.
Elderly patients: Age-related decline in renal function may necessitate dose modification.
Patients with a history of immune suppression (e.g., organ transplant recipients, HIV infection) should discuss the need for dose adjustment with their healthcare provider.
If patients are uncertain about any concurrent medication, supplement, or herb, they should inform their prescriber before starting Valtrex.
Dose adjustments for renal impairment are essential; the prescribing physician will calculate the appropriate reduction based on creatinine clearance.
Administration tips
Overdose management
Discontinuation
Regular follow-up appointments allow the prescriber to adjust dosing, address side effects, and reassess the need for continued antiviral therapy.
This article provides educational information about Valtrex and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Valacyclovir is excreted in breast milk in small amounts. While occasional short-term use is sometimes considered acceptable, a healthcare professional should evaluate the risk-benefit balance for each mother-infant pair.
When initiated within 72 hours of rash onset, Valtrex can reduce pain intensity and shorten the duration of lesions, often noticeable within the first 2-3 days of therapy.
In most markets, the 500 mg tablets are round and white, while the 1000 mg tablets are larger, oval, and may have a different imprint. Always verify the imprint code on the packaging.
Valacyclovir does not interfere with nucleic acid amplification tests (PCR) for SARS-CoV-2, nor does it affect antigen or antibody testing.
Valacyclovir is listed on the Hospital Authority’s Formulary for specific indications. Coverage depends on clinical necessity and physician prescription.
Yes, Valtrex may be carried in personal medication containers. Keep the original prescription label and declare the medication if required by the destination country’s customs regulations.
Take the missed dose as soon as you remember unless it is close to the time of the next scheduled dose. In that case, skip the missed dose and continue with the regular dosing schedule-do not double the dose.
The drug itself does not cause photosensitivity. However, shingles lesions may be sensitive; protect the affected area with loose clothing and avoid intense UV exposure until lesions have crusted.
Valacyclovir provides higher oral bioavailability, allowing for less frequent dosing (e.g., once or twice daily) compared with aciclovir, which often requires five times daily dosing.
Valacyclovir is approved for treatment of cold sores at the first sign of an outbreak, but it is not indicated for routine prophylaxis. Discuss preventive strategies with your healthcare provider.
